Physician

Robert David Schumaker, MD

According to 2025 Medicare claims, Robert Schumaker, MD (NPI: 1679573752) practices hematology/oncology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is TENNESSEE CANCER SPECIALISTS PLLC (NPI: 1841228871; TIN: 200677400) and primary practice location at 37909-1341.

Schumaker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 628 traditional Medicare patients, billed 214,523 HCPCS/CPT codes, and received $2,819,142 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,036 prescription claims across 241 beneficiaries totaling $3,247,065 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 29 claims. Open Payments data shows 152 records totaling $33,279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $938,430 to $3,247,065. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,291 to $2,970.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $1,587,201 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,844,263 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,730,554 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,502,315 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,755,966 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,752,640 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,528,091 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,097,829 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,999,797 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,819,142 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015488227,232$1,587,201
2016514207,322$1,844,263
2017547174,387$1,730,554
2018542188,876$2,502,315
2019570229,286$2,755,966
2020548263,471$2,752,640
2021582220,359$2,528,091
2022674232,572$2,097,829
2023777179,461$1,999,797
2024628214,523$2,819,142

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2015 Drug cost: $938,430 (USD; Tot_Drug_Cst)2016 Drug cost: $932,259 (USD; Tot_Drug_Cst)2017 Drug cost: $1,886,513 (USD; Tot_Drug_Cst)2018 Drug cost: $2,025,497 (USD; Tot_Drug_Cst)2019 Drug cost: $1,184,089 (USD; Tot_Drug_Cst)2020 Drug cost: $1,954,981 (USD; Tot_Drug_Cst)2021 Drug cost: $2,951,196 (USD; Tot_Drug_Cst)2022 Drug cost: $3,247,405 (USD; Tot_Drug_Cst)2023 Drug cost: $3,119,243 (USD; Tot_Drug_Cst)2024 Drug cost: $3,247,065 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152341,171$938,430
20162751,352$932,259
20172611,291$1,886,513
2018198974$2,025,497
2019205770$1,184,089
2020192741$1,954,981
2021214782$2,951,196
2022215897$3,247,405
2023213837$3,119,243
20242411,036$3,247,065

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$24K2015 Medicare payment: $24,068 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,641 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,751 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,114 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $3,709 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,402 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,491 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R125$24,068
2016N/R143$9,641
2017N/RN/RN/R
2018N/R11$1,751
2019N/R26$4,114
2020N/RN/RN/R
2021N/R56$3,709
20221140$2,402
20231129$5,491
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more400744$60
80053Blood test, comprehensive group of blood chemicals4901,572$10
36415Insertion of needle into vein for collection of blood sample4861,550$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4861,688$8
83615Lactate dehydrogenase (enzyme) level275427$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib28784$434,922
RevlimidLenalidomide34777$434,842
JakafiRuxolitinib Phosphate23690$308,660
LynparzaOlaparib12360$164,969
CalquenceAcalabrutinib Maleate11330$163,833

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.150$3,396Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.2$29,883AstraZeneca UK Limited
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert David Schumaker, MD?

Tedicare shows public-source Medicare data for Robert David Schumaker, MD (NPI 1679573752), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert David Schumaker, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert David Schumaker, MD?

Robert David Schumaker, MD is linked to TENNESSEE CANCER SPECIALISTS PLLC (billing NPI 1841228871) in the available physician profile data.

Does Robert David Schumaker, MD have Open Payments data?

Robert David Schumaker, MD has 152 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.